eltrombopag

Details

Generic Name:

eltrombopag

Project Status:

Not filed

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Brand Name:

Revolade

Project Line:

Reimbursement Review

Project Number:

N/A

Submission Type:

Non Submission

Indications:

Severe aplastic anemia

Recommendation Type:

CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer

Last Updated : August 15, 2019